Home >> Pharmaceuticals >> Food & Beverage >>

TapImmune Inc. - Product Pipeline Review - 2015

Published: Aug-2015 | Format: PDF | Global Markets Direct | Number of pages: 28 | Code: MRS - 35156

TapImmune Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘TapImmune Inc. - Product Pipeline Review - 2015’, provides an overview of the TapImmune Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of TapImmune Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of TapImmune Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of TapImmune Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the TapImmune Inc.’s pipeline products

Reasons to buy

- Evaluate TapImmune Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of TapImmune Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the TapImmune Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of TapImmune Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of TapImmune Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of TapImmune Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
TapImmune Inc. Snapshot 5
TapImmune Inc. Overview 5
Key Information 5
Key Facts 5
TapImmune Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
TapImmune Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
TapImmune Inc. - Pipeline Products Glance 10
TapImmune Inc. - Clinical Stage Pipeline Products 10
Phase I Products/Combination Treatment Modalities 10
TapImmune Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
TapImmune Inc. - Drug Profiles 12
TPIV-100 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
TPIV-110 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
TPIV-200 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
TPIV-120 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
TPIV-130 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
TPIV-300 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
TPIV-301 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
TapImmune Inc. - Pipeline Analysis 19
TapImmune Inc. - Pipeline Products by Target 19
TapImmune Inc. - Pipeline Products by Route of Administration 20
TapImmune Inc. - Pipeline Products by Molecule Type 21
TapImmune Inc. - Recent Pipeline Updates 22
TapImmune Inc. - Dormant Projects 25
TapImmune Inc. - Locations And Subsidiaries 26
Head Office 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 27
Disclaimer 28

List of Tables
TapImmune Inc., Key Information 5
TapImmune Inc., Key Facts 5
TapImmune Inc. - Pipeline by Indication, 2015 7
TapImmune Inc. - Pipeline by Stage of Development, 2015 8
TapImmune Inc. - Monotherapy Products in Pipeline, 2015 9
TapImmune Inc. - Phase I, 2015 10
TapImmune Inc. - Preclinical, 2015 11
TapImmune Inc. - Pipeline by Target, 2015 19
TapImmune Inc. - Pipeline by Route of Administration, 2015 20
TapImmune Inc. - Pipeline by Molecule Type, 2015 21
TapImmune Inc. - Recent Pipeline Updates, 2015 22
TapImmune Inc. - Dormant Developmental Projects,2015 25

List of Figures
TapImmune Inc. - Pipeline by Top 10 Indication, 2015 7
TapImmune Inc. - Pipeline by Stage of Development, 2015 8
TapImmune Inc. - Monotherapy Products in Pipeline, 2015 9
TapImmune Inc. - Pipeline by Top 10 Target, 2015 19
TapImmune Inc. - Pipeline by Top 10 Molecule Type, 2015 21

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)1500 View Pricing